Skip to main content

Table 1 Patients and disease characteristics in the entire population and according to adjuvant regimen

From: Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers

Characteristic

Total (N = 109)

G based (N = 43)

A based (N = 66)

P*

N (%)

N (%)

N (%)

Center

0.16

 INT

78 (72)

34 (79)

44 (67)

 IEO

31 (28)

9 (21)

22 (33)

Age

0.59

 Median

50

49

52

 IQR

43–57

43–56

44–59

Stage

0.59

 IA

20 (19)

7 (17)

13 (21)

 IB

83 (81)

35 (83)

48 (79)

 NA

6

1

5

Mitotic index

0.37

 Median

21

25

16

 IQR

12–34

14–34

12–33

 NA

55

16

39

Surgery

0.53

 LPT

90 (88)

34 (85)

56 (90)

 LPS

12 (12)

6 (15)

6 (10)

 NA

7

3

4

Morcellation

0.04

 No

52 (72)

15 (58)

37 (80)

 Yes

20 (28)

11 (42)

9 (20)

 NA

37

17

20

Oophorectomy

0.19

 No

27 (27)

13 (34)

14 (22)

 Yes

74 (73)

25 (66)

49 (78)

 NA

8

5

3

RT

0.05

 No

98 (90)

42 (98)

56 (85)

 Yes

11 (10)

1 (2)

10 (15)

  1. *Chi-square test, Fisher exact test or Mann-Whitney U test as appropriate
  2. INT Fondazione IRCCS Istituto Nazionale dei Tumori of Milan, IEO European Institute of Oncology, IQR interquartile range, G gemcitabine, A anthracycline, RT radiotherapy